Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
125.66
+0.70 (0.56%)
At close: Aug 29, 2025, 4:00 PM
125.70
+0.04 (0.03%)
After-hours: Aug 29, 2025, 7:00 PM EDT
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.74B in the quarter ending July 31, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $6.79B, up 4.48% year-over-year. In the fiscal year ending October 31, 2024, Agilent Technologies had annual revenue of $6.51B, down -4.73%.
Revenue (ttm)
$6.79B
Revenue Growth
+4.48%
P/S Ratio
5.27
Revenue / Employee
$379,218
Employees
17,900
Market Cap
35.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
A News
- 2 days ago - Agilent: Growth Across All Segments, But Investors Will Need To Be Patient - Seeking Alpha
- 3 days ago - Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results - Business Wire
- 3 days ago - Life sciences firm Agilent raises annual revenue outlook - Reuters
- 9 days ago - Agilent to Participate in 2025 Wells Fargo Healthcare Conference - Business Wire
- 10 days ago - Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer - Business Wire
- 17 days ago - Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment - Business Wire
- 26 days ago - Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs - Business Wire